Last reviewed · How we verify
NCT04116125: OBSERB
Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial
NA trial testing Radiotherapy in Breast Neoplasm Female in 1,380 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | Kyungpook National University Chilgok Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,380 |
| Start date | 1 July 2020 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 June 2025 |
Drugs / interventions tested
- Radiotherapy — full drug profile →
Conditions studied
- Breast Neoplasm Female — all drugs for Breast Neoplasm Female →
- Lymphatic Metastasis — all drugs for Lymphatic Metastasis →
Sponsor
Kyungpook National University Chilgok Hospital
Who can join
20 and older, female only, with Breast Neoplasm Female or Lymphatic Metastasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The OBSERB study is a multi-center, non-blinded, pragmatic, parallel, randomized controlled trial in which patients with cT1-3N1 and ycN0 breast cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04116125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Radiotherapy
Trials testing the same drug.
- NCT07497607 — Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma · Phase 2 · not yet recruiting
- NCT06813664 — ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) · Phase 2 · not yet recruiting
- NCT07339774 — Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients · Phase 2 · recruiting
- NCT07353671 — Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis · Phase 2, PHASE3 · recruiting
- NCT07245745 — Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer · NA · recruiting
Other recruiting trials for Breast Neoplasm Female
Currently open trials in the same condition.
- NCT07465523 — A Novel Approach in the Evaluation of Breast Masses With Doppler US · recruiting
- NCT06711523 — Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy · Phase 3 · active not recruiting
- NCT05277935 — Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib · NA · recruiting
- NCT06234137 — A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot · NA · recruiting
- NCT04812652 — Digitally Distributed Yoga for Women Treated for Breast Cancer · NA · active not recruiting
Other Kyungpook National University Chilgok Hospital trials
Trials by the same sponsor.
- NCT07066800 — Mindfulness Intervention for Maltreatment-Related Cognitive Decline · NA · active not recruiting
- NCT06903429 — Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery · NA · not yet recruiting
- NCT07511998 — A Randomized, Comparative, Controlled Study of Differences in the Incidence of Postoperative Sore Throat (POST) by Inner · NA · enrolling by invitation
- NCT06162390 — Optimal Concentration of Remifentanil for NIM Tube Intubation With Low-dose NMBA · NA · completed
- NCT05956054 — A Comparison of Intravascular Penetration With Curved Needle and Straight Needle During S1 STE · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04116125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kyungpook National University Chilgok Hospital
- Last refreshed: 4 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04116125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing